Abstract

The mastitis carcinomatosa or inflammatory breast is an aggressive form of mammary Tumors, it can be found in the usual different histological types with a low survival rate compared to that of other types of cancer, The diagnosis is mainly based on clinical and radiological criteria, MRI is more reliable in assessing tumor size than clinical examination, The most common presentation is a poorly limited heterogeneous infiltrating mass associated with thickening. The 5-year survival rate range 19-59% depends on the tumor stage. The treatment of inflammatory breast cancer is multidisciplinary, combining neoadjuvant chemotherapy followed by loco regional treatment.